Written answers

Thursday, 18 January 2024

Department of Health

Medicinal Products

Photo of Duncan SmithDuncan Smith (Dublin Fingal, Labour)
Link to this: Individually | In context | Oireachtas source

26. To ask the Minister for Health for a breakdown of the €20 million committed for new medicine funding in 2024; and if he will make a statement on the matter. [1974/24]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

In 2023, a new record of almost €3 billion was spent on medicines by the State. This represents nearly €1 in every €8 of public funding being spent on health. This unprecedented level of investment in our health services supports access for patients to the latest range of medicines.

Over the last 3 years the State has invested €98 million in new medicines to provide 148 new medicines or extended uses for medicines.

In 2024, I have tasked the HSE, my department, and all relevant agencies and stakeholders to place a priority focus on achieving the most efficient and effective use of available resources. This will require opportunities for savings to be identified and implemented.

€20 million of dedicated funding has been allocated for new medicines in 2024. I have also asked the HSE to ensure it realises at least €10 million in new additional efficiency gains. This money will be re-invested in new drugs and will ensure that the substantial investment in medicines is maximised to treat even more patients with new therapeutic innovations in the years to come.

This funding is in addition to substantial investment in resources to enhance the HSE’s medicines pricing and reimbursement process. These enhancements were a recommendation of the working group, which I established following the publication of the Mazars Report in February 2023.

Comments

No comments

Log in or join to post a public comment.